Novasep, Chromatide Extend Synthetic Peptide, Oligo Partnership | GenomeWeb
NEW YORK (GenomeWeb News) – Chromatide and Novasep have agreed to extend a research partnership focused on developing peptide and oligonucleotide synthesis technology, Novasep said Friday.
Novasep said the companies plan to combine its synthesis and purification services, which pharmaceutical companies use to produce pure peptides and oligonucleotides, with Chromatide’s experience in peptide and oligonucleotide synthesis, including production of novel resins and instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.